Bristol Myers Squibb: Pharma And Government Playing ‘Chicken’ Over New Drug Pricing (BMY)

0

Nadzeya Haroshka

Investment Overview – BMY’s Middling Position Within Big Pharma Industry

Bristol Myers Squibb (NYSE:BMY) is the US’ seventh largest pharmaceutical company by market cap, which stands at $123bn at the time of writing, with shares priced at ~$59 – down 27% from their all-time

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Please enter CoinGecko Free Api Key to get this plugin works.